Abstract
Over the last years, a number of neuronal systems using a different kind of neurotransmitter have been identified in the brain. The GABA and dopamine (DA) neuronal systems, due to their biological peculiarities, have attracted a considerable attention (for references see 34,53,64). The DA systems are, from an anatomical point of view, very well defined. Several ascending DA-pathways originating in the ventral mid-brain tegmentum (areas A9 and A10 according to Dahlström and Fuxe (10) give rise to fibers which innervate the neostriatum (nigro-neostriatal DA pathway), subcortical limbic regions such as nucleus accumbens and tuberculum olfactorium, cortical limbic regions (mesolimbic DA pathways), and the frontal cortex (mesocortical DA pathway). In addition, intrahypothalamic DA pathways such as the tubero-infundibular pathway, which originates in the nuc. Arcuatus and the ventral part of the periventricular hypothalamic nucleus and innervates the external layer of the median eminence, have been described (3,18,21,63). From a functional point of view, the nigroneostriatal and the meso-accumbens DA pathway seem to be important for sensorimotor integration; the tubero-infundibular pathway participates in neuroendocrine regulation, while most of the mesolimbic DA systems and the mesofrontal DA pathway may instead have a role in the control of higher brain functions (for references see 34,64). The GABA system, consisting of both Golgi I and Golgi II type neurons, includes neuronal pathways which innervate all the regions of the brain (61). This is the major inhibitory system and might participate in the regulation of nearly all the functions of the central nervous system (CNS), directly and/or through its synaptic influence on other neurotransmitter systems (for references see 53).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andén, N.-F., Butcher, S.G., Corrodi, H., Fuxe, K. and Ungerstedt U., Receptor activity and turnover rate of dopamine and nor-adrenaline after neuroleptics, J. Pharmacol. 11 (1970) 303–314.
Andén, N.-E., Corrodi, H. and Fuxe, K. Turnover studies using synthesis inhibition, In: G. Hooper, (Ed.), Metabolism of Amines in The Brain, McMillan, London, 1969, pp. 38–47.
Andén, N.-E., Dahlström, A., Fuxe, K., Larsson, K., Olson, L. and Ungerstedt, U., Ascending monoamine neurons to the telencephalon and diencephalon, Acta physiol. scand, 67 (1966) 313–326.
Andén, N.-E., Rubenson, A., Fuxe, K., Hökfelt, T., Evidence for dopamine receptor stimulation by apomorphine, J. Pharm. Pharmacol 19 (1967) 627–629.
Andén, N.-E. and Wachtel, H. Some effects of GABA and GABA-like drugs on central catecholamine mechanisms. In S. Grattini, J.F. Pujol and R. Samanin (Eds.), Interactions Between Putative Neurotransmitters in the Brain, Raven Press, New York, 1978, pp. 161–174.
Barber, R. and Saito, K. Light Microscopic Visualization of GAD and GABA-T in Immunocytochemical Preparations of Rodent CNS. In E. Roberts, T.N. Chase and D.B. Tower (Eds.), GABA in Nervous System Function, Raven Press, New York. 1976, pp. 113–132.
Bartholini, G. Interaction of dopamine, acetilcholine, and (-aminobutyric acid in limbic and striatal structures: Relation to therapy of schizophrenia. In De Ajuriaguerra, J. and Tissot, R. (Eds.) Rhinencephale, Neurotransmetterus et Sychoses. Masson, Paris, 1977 pp. 241–251.
Brownstein, M., Palkovits, M., Tappaz, M., Saavedra, J. and Kizer, S., Effect of surgical isolation of the hypothalamus on its neurotransmitter content, Brain Res. 117 (1976) 287–295.
Cuello, A.C. and Iversen, L.L. Interactions of dopamine with other neurotransmitters in the rat substantia nigra: A possible functional role of dendritic dopamine. In Grattini, S., Pujol. P.J. and Samanin, R. (Eds.) Interactions Between Putative Neurotransmitters in the Brain Raven Press, New York, 1978, pp. 127149.
Dahlstrom, A. and Fuxe, K., Evidence for the existence of monoamine containing neurons in the central nervous system. I, Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand, 62, Suppl. 232 (1964) 1–55.
Eccles, J.C., Ito, M. and Szentagothai, J., The Cerebellum as a Neural Machine. Springer-Verlag, New York, 1967.
Einarsson, P., Hallman, P. and Jonsson, G., Quantitative microfluorimetry of formaldehyde-induced fluorescence of dopamine in the caudate nucleus. Med. Biol 53 (1975) 15–24.
Fonnum, F., Grofovg, I., Rinvik, E., Storm-Mathisen, J. and Walberg. F., Origin and distribution of glutamate decarboxylase in substantia nigra of the cat, Brain Res, 71 (1974) 77–92.
Fonnum, F., Storm-Mathisen, J. and Walberg, F., Glutamate decarboxylase in inhibitory neurons. A study of the enzyme in Purkinje cell axons and boutons in the cat Brain Res, 20 (1970) 259–275.
Fonnum, F., Walaas, I. and Iversen, E. Localization of gabaergic, cholinergic and aminergic structures in the mesolimbic system, J. Neurochem, 29 (1977) 221–230.
Fuxe, K., Andersson K., Ogren S-0, Pérez de la Mora M., Schwarcz R., Hökfelt T., Eneroth P., Gustafsson J-A Skett P., GABA neurons and their interaction with monoamine neurons. An anatomical, pharmacological and functional analysis. In P. Krogsgaard-Larsen, J. Scheel-Kruger and H. Kofod (Eds.) GABA Neurotransmitters. Pharmacological, Biochemical and Pharmacological Aspects, Munksgaard, Copenhagen, 1979, pp. 74–94.
Fuxe, K., Andersson, K., Schwarcz, R., Agnati, L.F., Pérez de la Mora, M. Hökfelt, T., Goldstein M., Ferland, L., Possaní, L. and Tapia, R., Studies on different types of dopamine nerve terminals in the forebrain and their possible interactions with hormones and with neurons containing GABA, glutamate and opioid peptides, In L.J. Poirier, T.L. Sourkes and P.J. Bedard (Eds.), Advances in Neurology, Vol. 24, Raven Press, New York, 1979, pp. 199–216.
Fuxe, K., Hökfelt, T., Agnati, L.F., Johansson, 0., Goldstein, M., Pérez de la Mora, M., Possani, L., Tapia, R., Tergn, L. and Palacios, R. Mapping out central catecholamine neurons: Immunohistochemical studies on catecholamine-synthesizing enzymes. In M.A. Lipton, A. Di Mascio and K.F. Killam (Eds.), Psycho-pharmacology. A Generation of Progress, Raven Press, New York, 1978, pp. 67–94.
Fuxe, K., Hökfelt, T., Agnati, L., Ljungdahl, A., Johansson, 0. and Pérez de la Mora, M., Evidence for an inhibitory gabaergic control of the mesolimbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs, Med. Biol, 53 (1975) 177–183.
Fuxe, K., Hökfelt, T., Johansson, 0., Ganten, D., Goldstein, M., Pérez de la Mora, M., Possani, L., Tapia, R., Tergn, L., Palacios, R., Said, S. & Mutt, V. Monoamine neuron system in the hypothalamus and their relation to the GABA and peptide-containing neurons. In Mornex, R. and Barry, J. Neuromediateurs et Polypeptides Hypothalamiques a Action Relachante ou Inhibitrice, Institut National de la Sante et de la Recherche Medicale, Paris, 1977, pp. 17–40.
Fuxe, K., Hökfelt, T. and Ungerstedt, U., Morphological and functional aspects of central monoamine neurons. In International Review of Neurobiology, Vol. 13, Academic Press, New York. 1970, pp. 93–126.
Fuxe, K., Ogren, S.-0., Fredholm, B., Agnati, L., Hökfelt, T. and Pérez de la Mora, M., Possibilities of a differential blockade of central monoamine receptors. In De Ajuriaguerra, J. and Tissot, R. (Eds.) Rhinencéphale Neurotransmetteurs et Sychoses Masson, Paris, 1977, pp. 253–289.
Fuxe, K., Pérez de la Mora, M., Hökfelt, T., Agnati, L., Ljungdahl, A., and Johansson, 0. GABA-DA interactions and their possible relation to schizophrenia. In C. Shagaas, S. Gershon and A.J. Friedhof (Eds.) Psychopathology and Brain Dysfunction Raven Press, New York, 1977, pp. 97–111.
Hökfelt, T., Elde, R., Fuxe, K., Johansson, 0., Ljungdahl, A. Goldstein, M., Luft, R., Efendic, S., Nilsson, G., Terenius, L., Ganten, D., Jeffcoate, S.L., Rehfeld, J., Said, S., Pérez de la Mora, M., Possani, L., Tapia, R., Tergn, L. and Palacios, R. Aminergic and peptidergic pathways in the nervous system with special reference to the hypothalamus. In S. Reichlin, R.J. Baldessarini and J.B. Martin (Eds.), The Hypothalamus, Raven Press, New York, 1978, pp. 69–135.
Hökfelt, T. and Ljungdahl, A. Uptake mechanisms as a basis for the histochemical identifie ation and tracing of transmitter specific neuron populations, In W.M. Cotman and M. Cuénod (Eds.), The Use of Axonal Transport for Studies of Neuronal Connectivity, Elsevier Scientific Publishing Co., Amsterdam, 1975, pp. 251–305.
Iversen, L.L. and Schon, F. The use of autoradiographie techniques for the identification and mapping of transmitter specific neurons in CNS. In A. Mandel and D. Segal (Eds.) New Concepts of Transmitter Regulation Plenum Press, New York, 1973, pp. 153–193.
Javoy, F., Agid, Y. and Glowinski, J., Oxotremorine and atropine-induced changes of dopamine metabolism in the rat striatum. J. Pharm. Pharmacol 27 (1975) 677–681.
Johnston, G.A.R. Physiologic pharmacology of GABA and its antagonists in the vertebrate nervous system. In Roberts, E. Chase, T.N. and Tower, D.B. (Eds.) GABA in Nervous System Function, Raven Press, New York, 1976, pp. 395–411.
Joseph-Nathan, P., Massieu, G., Carvajal, P. and Tapia, R., y-Hydroxy-y-Phenyl, Caproamide, an anticonvulsant molecule, Rev. Latinoamer. Quím 9 (1978) 90–92.
Kim, J.S., Bak, I.J., Hassler, R. and Okada, Y., Role of y-aminobutyric acid (GABA) in the extrapyramidal motor system. 2. Some evidence for the existence of a type of GABA-rich strionigral neurons, Exp. Brain Res, 14 (1971) 95–104.
Krogsgaard-Larsen, P., Johnston, G.A.R., Curtis, D.R., Game, C.J.A., and McCulloch, R.M., Structure and biological activity of a series of conformotionally restricted analogues of GABA, J. Neurochem. 25 (1975) 203–209.
Ladinsky, H., Consolo, S., Bianchi, S. and Jori, A., Increase in striatal acetylcholine by picrotoxin in the rat: evidence of a gabaergic-dopaminergic-cholinergic link, Brain Research, 108 (1976) 351–361.
Lasher, R.S., The Uptake of (3H) GABA and differentiation of stellate neurons in cultures of dissociated postnatal rat cerebellum, Brain Res. 69 (1974) 235–254.
Lipton, M.A., DiMascio, A. and Killam, K.F. (Eds.), Psycho-pharmacology: A Generation of Progress, Raven Press, New York, 1978.
Mao, C.C., Cheney, D.L., Marco, E., Revuelta, A. and Costa, E. Turnover times of gamma-aminobutyric acid and acetylcholine in nucleus caudatus, nucleus accumbens, globus pallidus and substantia nigra: Effects of repeated administration of haloperidol, Brain Res. 132 (1977) 375–379.
Mao, C.C., Marco, E., Revuelta,A. and Costa, E., Antysychotics and GABA turnover in mammalian brain nuclei. In Grattini, S., Pujol, J.F. and Samanin, R. (Eds.), Interactions Between Putative Neurotransmitters in the Brain, Raven Press, New York, 1978, pp. 151–160.
Massieu, G.H., Tapia, R., Pasantes, H.O. and Ortega, B.G. Convulsant effect of L-glutamic acid-y-hydrazide by simultaneous treatment with pyridoxal phosphate, Biochem. Pharmacol 13 (1964) 118–120.
Matsuda, T., Wu, J.-Y. and Roberts, E., Immunochemical studies on glutamic acid decarboxylase (EC 4.1.1.15) from mouse brain, J. Neurochem. 21 (1977) 159–166.
Matsuda, T., Wu, J.-Y. and Roberts, E., Electrophoresis of glutamic acid decarboxylase (EC 4.1.1.15) from mouse brain in sodium dodecyl sulphate polyacrylamide gels, J. Neurochem, 21 (1973) 167–172.
McGeer, P.L., Fibiger, H.C., Maler, M., Hattori, T. and McGeer E.G., Evidence for descending pallido-nigral GABA-containing neurons. In F. MacDowell and A. Barbeau (Eds.), Advances in Neurology, Vol. 3, Raven Press, New York, 1974, pp. 153–163.
Obata, K. Ito, M., Ochi, R. and Sato, N. Pharmacological properties of the postsynaptic inhibition by Purkinje cell axons and the action of y-aminobutyric acid on Deiters neurons, Exp. Brain Res 4 (1967) 43–57.
Pérez de la Mora, M. and Fuxe, K. Brain GABA, dopamine and acetylcholine interactions. I. Studies with oxotremorine, Brain Res, 135 (1977) 107–122.
Pérez de la Mora, M., Fuxe, K., Andersson, K., Hökfelt, T., Ljungdahl, A. Possani, L. and Tapia, R. Studies on GABA-monoamine and GABA-endorphin interactions. In E. Usdin, I.J. Kopin and J. Barchas (Eds.), Catecholamines: Basic and Clinical Frontiers, Pergamon Press, New York, 1979, Vol. II, pp. 1032–1034.
Pérez de la Mora, M., Fuxe, K., Hökfelt, T. and Ljungdahl, A. Effect of apomorphine on the GABA turnover in the DA cell group rich area of the mesencephalon. Evidence for the involvement of an inhibitory gabergic feedback control of the ascending DA neurons, Neurosci. Lett, 1 (1975) 109–114.
Pérez de la Mora, M., rune, K-; Hökfelt, T. and Ljungdahl, A. Further evidence that apomorphine increases GABA turnoveL in the cell body rich and DA nerve terminal rich areas of the brain, Neurosci. Lett 2 (1976) 239–241.
Pérez de la Mora, M., Fuxe, K. Hökfelt, T. and Ljungdahl, A. Evidence for a nerve impulse-dependent GABA accumulation in the substantía nígra after treatment with y-glutamylhydrazide, Neurosci. Lett. 5 (1977) 75–82.
Pérez de la Mora, M., and Tapia, R. Anticonvulsant effect of 5-ethyl, 5-phenyl, 2-pirrolidinone and its possible relationship to y-aminobutyric acid-dependent inhibitory mechanisms, Bíochem. Pharmacol 22 (1973) 2635–2639.
Possani, L.D., Bayón, A. and Tapia, R., Synthesis of affinity chromatographic resins for the purification of brain glutamate decarboxylase, Neurochem. Res. 2 (1977) 51–57.
Racagni, G., Apud, J.A., Locatelli, V. Cocchi, D., Nistico, G. di Giorgio, R.M. and Muller, E. E. GABA of CNS origin in the rat anterior pituitary inhibits prolactín secretion. Nature (Lond.) 281 (1979) 575–578.
Racagni, G. Bruno. Interactions among dopamine, acetylcholine, and GABA in the nigrostriatal system, In: Grattiní, S. Pujol, J.F. and Samanin, R. (Eds.) Interactions Between Putative Neurotransmitters in the Brain, Raven Press, New York, 1978, pp. 61–72.
Reubi, J.C., Iversen, L.L. and Jessel, T.M. Dopamine selectively increases 3H-GABA release from slices of rat substantía nigra in vitro, Nature 268 (1977) 652–653.
Ribak, C.E., Vaughn, J.E., Saito, K., Barber, R. and Roberts, E., Immunocytochemical localization of glutamate decarboxylase in rat substantia nigra, Brain Res. 116 (1976) 287–298.
Roberts, E., Chase, T.N. and Tower, D.B. (Eds.), GABA in Nervous System Function, Raven Press, New York, 1976.
Saito, K., Barber, R., Wu, J-Y., Matsuda, T., Roberts, E. and Vaughn, J.E., Immunohistochemical localization of glutamate decarboxylase in rat cerebellum, Proc. Nat. Acad. Sci. USA, 71 (1974) 269–273.
Saito, K. Wu, J.-Y., Matsuda, T. and Roberts, E. Immunochemical comparisons of vertebrate glutamic acid decarboxylase, Brain Res 65 (1974) 277–285.
Schechter, P., Tranier Y., Jung, M.J. and Bohlen, P. Audiogenic seizure protection by elevated brain GABA concentration in mice: Effects of Y-acetylenic GABA and Y-vinyl GABA, two irreversible GABA-T inhibitors. Europ. J. Pharmacol 45 (1977) 319–328.
Scheel-Kruger, J., Arnt, J., Braestrup, C., Christensen, A.V. and Mageluno, E., Development of new animal models for GABAergic actions using muscimol as a tool. In P. Krogsgaard-Larsen, J. Scheel-Kruger and H. Kofod (Eds.), GABA-Neurotransmitters, Pharmacochemical, Biochemica l and Pharmacological Aspects, Munksgaard, Copenhagen, 1979, pp. 447–464.
Sotelo, C. Privat, A. and Drian, M.-J. Localization of (3H) GABA in tissue culture of rat cerebellum using electron microscopy radioautography, Brain Res, 61 (1972) 379–384.
Tapia, R., Biochemical Pharmacology of GABA in CNS In: Iversen L.L., Iversen, S.D. and Snyder, S.H. (Eds.) Handbook of Psychopharmacology Vol. 4. Plenum Publishing Co., New York, 1975, pp. 1–58
Tapia, R., Drucker-Colin, R.R., Meza-Ruiz, G., Duran, L. and Levi G. Neurophysiological and neurochemical studies on the action of the anticonvulsant Y-hydroxy, Y-ethyl, Y-phenyl-butyramide, Epilepsia 20 (1979) 135–145.
Tappaz, M.L., Brownstein, M.J. and Palkovits, M., Distribution of glutamate decarboxylase in discrete brain nuclei, Brain Res. 108 (1976) 371–380.
Tappaz, M.L. and Brownstein, M.J., Origin of glutamate decarboxylase (GAD) containing cells in discrete hypothalamic nuclei, Brain Res. 132 (1977) 95–106.
Ungerstedt, U. Stereotaxic mapping of the monoamine pathway in the rat brain. Acta physiol. scand, 82 (1971) 1–48.
Usdin, E., Kopin, I.J. and Barchas J. (Eds.), Catecholamines: Basic and Clinical Frontiers. Pergamon Press, New York, 1979.
Walaas, I. and Fonnum, F. The effect of parenteral glutamate treatment on the localization of neurotransmitters in the mediobasal hypothalamus, Brain Res, 153 (1978) 549–562.
Waalas, I. and Fonnum, F., The distribution and origin of glutamate decarboxylase and choline acetyltransferase in ventral pallidum and other basal forebrain regions, Brain Res. 117 (1979) 325–336.
Wiesel, F.A. and Seduall, G. The effect of antipsychotic drugs on homovanillic acid levels in striatum and olfactory tubercle of the rat, Europ. J. Pharmacol 30 (1975) 364–367.
Wood, J.G. McLaughlin, B.J. and Vaughn, J.E. Immunocytochemical localization of GAD in electron microscopic preparations of rodent CNS. In E. Roberts, T.N. Chase and D.B. Tower (Eds.), GABA in Nervous System Function, Raven Press, New York, 1976, pp. 133–148.
Yoshida, M. and Precht, W., Monosynaptic inhibition of neurons of the substantia nigra by caudate-nigral fibers, Brain Res. 32 (1971) 225–228.
Wochwa, S., Immunoelectrophoresis (including zone electrophoresis), In N.R. Rose and H. Friedman (Eds.), Manual of Clinical Immunology, American Society for Microbiology, Washington, D.C. 1976, pp. 17–35.
Wu, J.-Y., Matsuda, T. and Roberts, E., Purification and characterization of glutamate decarboxylase from mouse brain, J. Biol. Chem 248 (1973) 3029–3034.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Plenum Press, New York
About this chapter
Cite this chapter
de la Mora, M.P., Fuxe, K., Hökfelt, T., Andersson, K., Possani, L., Tapia, R. (1981). Gabaergic Synapses: Distribution and Interaction with Other Neurotransmitter Systems in the Brain. In: Tapia, R., Cotman, C.W. (eds) Regulatory Mechanisms of Synaptic Transmission. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3968-7_5
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3968-7_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3970-0
Online ISBN: 978-1-4684-3968-7
eBook Packages: Springer Book Archive